| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_863785e4f0e730175e0f6a095ac08a27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4cc9a89023d6c98a2515c4f0fcf33b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b2a85bbdaeb3a8ae0580f899a255f61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0d6696ab424c2858ea0f81bf36a289c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79f85bec037c26af5c23a02704f6ea89 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-026 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06 |
| filingDate |
2010-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00b30808f2f62efba5e229eed98eefb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a23f04dbaee38a22ee05a0b5efaef5c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3559587d10cfc1186bec770576bc2ece |
| publicationDate |
2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012231029-A1 |
| titleOfInvention |
Enhanced malaria msp-1 subunit vaccine |
| abstract |
Recombinant subunit proteins derived from the MSP-1 C-terminal region of the parasite Plasmodium falciparum are described that have enhanced immunogenic properties. Selected regions of p33 have been combined with p19 to enhance the immunogenic potential of the p19 core region. As the constructs represent discontinuous segments fused to create unique proteins, the recombinant proteins expressed are not found in nature. The enhanced immunogenic potential of the disclosed recombinant proteins provided for strong, consistent and specific antibody responses. The disclosed recombinant subunit proteins are vaccine candidates for protection against infection with malaria. |
| priorityDate |
2009-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |